The DEA recently suspended McKesson Corporation’s sales of controlled substances from distribution in Florida. This suspension could impact your patients’ ability to fill their prescriptions and you may want to advise them about the potential implications. As a practitioner, you should be aware of the possibility of drug shortages and consider alternative treatment options when prescribing controlled substances. As always, use your best professional judgment when caring for your patients.
Please see the link to the news release below: https://www.dea.gov/divisions/hq/2017/hq011717.shtml